BS
Bhagvatilal Shantilal Inani
About Bhagvatilal Shantilal Inani
Data last updated:
Bhagvatilal Shantilal Inani is a Director at Sabwell Pharmaceuticals Private Limited (since 2023) and Director at Fulcare Pharmaceutical Private Limited (since 2019). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹65 Lakh; the largest is Sabwell Pharmaceuticals Private Limited at ₹37.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sabwell Pharmaceuticals Private Limited U24290GJ2023PTC138555 | Director | 20 Jan 2023 | 2023 | ₹37.3 Lakh (FY 2024) | Active |
| Fulcare Pharmaceutical Private Limited U36999GJ2018PTC100562 | Director | 07 Jun 2019 | 2018 | ₹27.8 Lakh (FY 2024) | Active |
Board colleagues of Bhagvatilal Shantilal Inani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Jayant Ghube | 09864323 | Sabwell Pharmaceuticals Private Limited | Director |
| Sunitaben Bhagvatilal Inani | 08034235 | Fulcare Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhagvatilal Shantilal Inani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhagvatilal Shantilal Inani
Bhagvatilal Shantilal Inani currently holds 2 directorships: Sabwell Pharmaceuticals Private Limited (Director, since 20 Jan 2023, revenue ₹37.3 Lakh (FY 2024)); Fulcare Pharmaceutical Private Limited (Director, since 07 Jun 2019, revenue ₹27.8 Lakh (FY 2024)).
Bhagvatilal Shantilal Inani was first appointed on 07 Jun 2019 as Director at Fulcare Pharmaceutical Private Limited. The most recent appointment on record is 20 Jan 2023 at Sabwell Pharmaceuticals Private Limited.
The 2 current companies of Bhagvatilal Shantilal Inani that report revenue have a combined latest revenue of ₹65 Lakh: Sabwell Pharmaceuticals Private Limited ₹37.3 Lakh (FY 2024); Fulcare Pharmaceutical Private Limited ₹27.8 Lakh (FY 2024).
The current boards of Bhagvatilal Shantilal Inani's companies include Amit Jayant Ghube (Sabwell Pharmaceuticals Private Limited), Sunitaben Bhagvatilal Inani (Fulcare Pharmaceutical Private Limited).